Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
26.96
-0.79 (-2.83%)
Mar 11, 2026, 4:00 PM EDT - Market closed
Surrozen Market Cap
Surrozen has a market cap or net worth of $251.3 million as of March 11, 2026. Its market cap has increased by 581.89% in one year.
Market Cap
251.30M
Enterprise Value
177.04M
1-Year Change
581.89%
Ranking
Category
Stock Price
$26.96
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $251.30M, an increase of 108.28%. That is a compound annual growth rate of 15.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 258.61M | 22.74% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 262.00M |
| Fennec Pharmaceuticals | 258.54M |
| Prelude Therapeutics | 257.08M |
| Palisade Bio | 257.03M |
| Inhibikase Therapeutics | 251.68M |
| Cibus | 244.55M |
| Alector | 241.69M |
| Nuvectis Pharma | 240.94M |